• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019年冠状病毒病(COVID-19):重点关注褪黑素的安全性和治疗效果。

The Coronavirus Disease 2019 (COVID-19): Key Emphasis on Melatonin Safety and Therapeutic Efficacy.

作者信息

Ramos Eva, López-Muñoz Francisco, Gil-Martín Emilio, Egea Javier, Álvarez-Merz Iris, Painuli Sakshi, Semwal Prabhakar, Martins Natália, Hernández-Guijo Jesús M, Romero Alejandro

机构信息

Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Complutense University of Madrid, 28040 Madrid, Spain.

Faculty of Health Sciences, University Camilo José Cela, C/Castillo de Alarcón 49, Villanueva de la Cañada, 28692 Madrid, Spain.

出版信息

Antioxidants (Basel). 2021 Jul 20;10(7):1152. doi: 10.3390/antiox10071152.

DOI:10.3390/antiox10071152
PMID:34356384
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8301107/
Abstract

Viral infections constitute a tectonic convulsion in the normophysiology of the hosts. The current coronavirus disease 2019 (COVID-19) pandemic is not an exception, and therefore the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, like any other invading microbe, enacts a generalized immune response once the virus contacts the body. Melatonin is a systemic dealer that does not overlook any homeostasis disturbance, which consequently brings into play its cooperative triad, antioxidant, anti-inflammatory, and immune-stimulant backbone, to stop the infective cycle of SARS-CoV-2 or any other endogenous or exogenous threat. In COVID-19, the corporal propagation of SARS-CoV-2 involves an exacerbated oxidative activity and therefore the overproduction of great amounts of reactive oxygen and nitrogen species (RONS). The endorsement of melatonin as a possible protective agent against the current pandemic is indirectly supported by its widely demonstrated beneficial role in preclinical and clinical studies of other respiratory diseases. In addition, focusing the therapeutic action on strengthening the host protection responses in critical phases of the infective cycle makes it likely that multi-tasking melatonin will provide multi-protection, maintaining its efficacy against the virus variants that are already emerging and will emerge as long as SARS-CoV-2 continues to circulate among us.

摘要

病毒感染是宿主正常生理机能中的一场剧烈动荡。当前的2019冠状病毒病(COVID-19)大流行也不例外,因此,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染与其他任何入侵微生物一样,一旦病毒接触人体,就会引发全身性免疫反应。褪黑素是一种全身性的调节物质,不会忽视任何内稳态紊乱,因此会发挥其协同三联体(抗氧化、抗炎和免疫刺激支柱)的作用,以阻止SARS-CoV-2或任何其他内源性或外源性威胁的感染周期。在COVID-19中,SARS-CoV-2在体内的传播涉及加剧的氧化活性,因此会产生大量活性氧和氮物种(RONS)。褪黑素在其他呼吸道疾病的临床前和临床研究中广泛证明的有益作用,间接支持了将其作为当前大流行可能的保护剂的观点。此外,将治疗作用集中在加强感染周期关键阶段的宿主保护反应上,使得具有多种功能的褪黑素有可能提供多重保护,对已经出现以及只要SARS-CoV-2继续在我们中间传播就会出现的病毒变体保持其疗效。

相似文献

1
The Coronavirus Disease 2019 (COVID-19): Key Emphasis on Melatonin Safety and Therapeutic Efficacy.2019年冠状病毒病(COVID-19):重点关注褪黑素的安全性和治疗效果。
Antioxidants (Basel). 2021 Jul 20;10(7):1152. doi: 10.3390/antiox10071152.
2
Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19.褪黑素可能是一种辅助剂,可改善患有肥胖症和糖尿病且同时感染新冠病毒的个体的临床结局。
Eur J Pharmacol. 2020 Sep 5;882:173329. doi: 10.1016/j.ejphar.2020.173329. Epub 2020 Jun 30.
3
A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.一种基于三聚体 RBD 的马赛克型 COVID-19 疫苗候选物可诱导针对奥密克戎和其他 SARS-CoV-2 变体的强大中和作用。
Elife. 2022 Aug 25;11:e78633. doi: 10.7554/eLife.78633.
4
A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial.一项评估褪黑素预防高危接触者 SARS-CoV-2 感染有效性的随机多中心临床试验(MeCOVID 试验):一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 3;21(1):466. doi: 10.1186/s13063-020-04436-6.
5
Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.羟氯喹用于接触新冠病毒疾病(COVID-19)后成年人暴露者预防严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染的暴露后预防效果:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 3;21(1):475. doi: 10.1186/s13063-020-04446-4.
6
Targeting Host Defense System and Rescuing Compromised Mitochondria to Increase Tolerance against Pathogens by Melatonin May Impact Outcome of Deadly Virus Infection Pertinent to COVID-19.通过褪黑素靶向宿主防御系统和挽救受损的线粒体来提高对病原体的耐受性可能会影响与 COVID-19 相关的致命病毒感染的结果。
Molecules. 2020 Sep 25;25(19):4410. doi: 10.3390/molecules25194410.
7
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
8
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染:综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
9
COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions.新冠疫情和疫苗更新:挑战与解决方案。
Front Cell Infect Microbiol. 2021 Sep 10;11:690621. doi: 10.3389/fcimb.2021.690621. eCollection 2021.
10
Can Melatonin Be a Potential "Silver Bullet" in Treating COVID-19 Patients?褪黑素能否成为治疗新冠患者的潜在“万灵药”?
Diseases. 2020 Nov 26;8(4):44. doi: 10.3390/diseases8040044.

引用本文的文献

1
Mitochondria in COVID-19: from cellular and molecular perspective.新型冠状病毒肺炎中的线粒体:从细胞和分子角度看
Front Physiol. 2024 Jun 21;15:1406635. doi: 10.3389/fphys.2024.1406635. eCollection 2024.
2
Redox Homeostasis Alteration Is Restored through Melatonin Treatment in COVID-19 Patients: A Preliminary Study.褪黑素治疗可恢复新冠患者的氧化还原稳态改变:一项初步研究
Int J Mol Sci. 2024 Apr 21;25(8):4543. doi: 10.3390/ijms25084543.
3
A mid‑pandemic night's dream: Melatonin, from harbinger of anti‑inflammation to mitochondrial savior in acute and long COVID‑19 (Review).大流行期间的一个午夜之梦:褪黑素,从抗炎先兆到急性和长新冠 COVID-19 中的线粒体救星(综述)。
Int J Mol Med. 2024 Mar;53(3). doi: 10.3892/ijmm.2024.5352. Epub 2024 Feb 1.
4
Non-Excitatory Amino Acids, Melatonin, and Free Radicals: Examining the Role in Stroke and Aging.非兴奋性氨基酸、褪黑素与自由基:探讨其在中风和衰老中的作用
Antioxidants (Basel). 2023 Oct 10;12(10):1844. doi: 10.3390/antiox12101844.
5
Can melatonin reduce the severity of post-COVID-19 syndrome?褪黑素能否减轻新冠后综合征的严重程度?
EXCLI J. 2023 Feb 2;22:173-187. doi: 10.17179/excli2023-5864. eCollection 2023.
6
The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications.缺血再灌注损伤在类风湿性关节炎、长新冠和 ME/CFS 等慢性、复发性疾病中的潜在作用:证据、机制和治疗意义。
Biochem J. 2022 Aug 31;479(16):1653-1708. doi: 10.1042/BCJ20220154.
7
A Review of the Potential Effects of Melatonin in Compromised Mitochondrial Redox Activities in Elderly Patients With COVID-19.褪黑素对老年 COVID-19 患者线粒体氧化还原活性受损的潜在影响综述
Front Nutr. 2022 Jun 20;9:865321. doi: 10.3389/fnut.2022.865321. eCollection 2022.
8
SARS-CoV-2 Neuroinvasion, Inflammatory Neurodegeneration and Alzheimer's Disease.严重急性呼吸综合征冠状病毒2型神经侵袭、炎症性神经退行性变与阿尔茨海默病
Front Cell Neurosci. 2022 Jun 17;16:937961. doi: 10.3389/fncel.2022.937961. eCollection 2022.
9
Melatonin drugs inhibit SARS-CoV-2 entry into the brain and virus-induced damage of cerebral small vessels.褪黑素药物可抑制 SARS-CoV-2 进入大脑和病毒引起的大脑小血管损伤。
Cell Mol Life Sci. 2022 Jun 13;79(7):361. doi: 10.1007/s00018-022-04390-3.
10
[Sleep disorders and fatigue syndrome in long COVID syndrome: case-based experiences from neurological/sleep medicine rehabilitation].[长新冠综合征中的睡眠障碍与疲劳综合征:神经科/睡眠医学康复的病例经验]
Somnologie (Berl). 2022;26(2):73-79. doi: 10.1007/s11818-022-00353-9. Epub 2022 May 30.

本文引用的文献

1
Network Analysis and Transcriptome Profiling Identify Autophagic and Mitochondrial Dysfunctions in SARS-CoV-2 Infection.网络分析和转录组分析揭示新冠病毒感染中的自噬和线粒体功能障碍
Front Genet. 2021 Mar 16;12:599261. doi: 10.3389/fgene.2021.599261. eCollection 2021.
2
The melatonergic pathway and its interactions in modulating respiratory system disorders.褪黑素能途径及其对呼吸系统疾病的调节作用。
Biomed Pharmacother. 2021 May;137:111397. doi: 10.1016/j.biopha.2021.111397. Epub 2021 Feb 19.
3
Melatonin may decrease risk for and aid treatment of COVID-19 and other RNA viral infections.褪黑素可能降低 COVID-19 和其他 RNA 病毒感染的风险并有助于治疗。
Open Heart. 2021 Mar;8(1). doi: 10.1136/openhrt-2020-001568.
4
Metabolic dysfunction and immunometabolism in COVID-19 pathophysiology and therapeutics.代谢功能障碍与免疫代谢在 COVID-19 病理生理学与治疗学中的作用
Int J Obes (Lond). 2021 Jun;45(6):1163-1169. doi: 10.1038/s41366-021-00804-7. Epub 2021 Mar 16.
5
Antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by COVID-19.抗氧化剂和己酮可可碱作为标准治疗的辅助措施,以改善新型冠状病毒肺炎患者的预后。
Comput Struct Biotechnol J. 2021;19:1379-1390. doi: 10.1016/j.csbj.2021.02.009. Epub 2021 Feb 27.
6
SARS-CoV-2 and other coronaviruses negatively influence mitochondrial quality control: beneficial effects of melatonin.SARS-CoV-2 和其他冠状病毒会对线粒体质量控制产生负面影响:褪黑素的有益作用。
Pharmacol Ther. 2021 Aug;224:107825. doi: 10.1016/j.pharmthera.2021.107825. Epub 2021 Mar 1.
7
Autism Spectrum Disorder patients may be susceptible to COVID-19 disease due to deficiency in melatonin.自闭症谱系障碍患者可能由于褪黑素缺乏而容易感染 COVID-19 疾病。
Med Hypotheses. 2021 Apr;149:110544. doi: 10.1016/j.mehy.2021.110544. Epub 2021 Feb 18.
8
Commentary: Antifibrotics in COVID-19 Lung Disease: Let Us Stay Focused.评论:COVID-19肺部疾病中的抗纤维化药物:让我们保持专注。
Front Med (Lausanne). 2021 Jan 11;7:625440. doi: 10.3389/fmed.2020.625440. eCollection 2020.
9
Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis.SARS-CoV-2 患者的合并症:系统评价和荟萃分析。
mBio. 2021 Feb 9;12(1):e03647-20. doi: 10.1128/mBio.03647-20.
10
Tryptophan Metabolites and Aryl Hydrocarbon Receptor in Severe Acute Respiratory Syndrome, Coronavirus-2 (SARS-CoV-2) Pathophysiology.色氨酸代谢物和芳烃受体在严重急性呼吸综合征、冠状病毒-2 (SARS-CoV-2) 发病机制中的作用。
Int J Mol Sci. 2021 Feb 5;22(4):1597. doi: 10.3390/ijms22041597.